Tsutomu Mizoshita

Nagoya City University — Japan

Medicine · Health Sciences

31h-index3.5kcitations184works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Helicobacter pylori-related gastroenterology studies(58), Gastric Cancer Management and Outcomes(31), Inflammatory Bowel Disease(22), Digestive system and related health(20), Microscopic Colitis(17)

Publications183 total

The Low Platelet Count at the Start of Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma Predicts Deteriorated Liver Function at the Time of Disease Progression Thereafter: A Multicenter Analysis
Hepatology Research·2025· 1 cited
The Neutrophil-to-Lymphocyte Ratio during Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma Predicts Long-Term Therapeutic Efficacy: A Multicenter Analysis
Oncology·2025· 1 cited
Number of Tumors Stratifies the Therapeutic Response to Atezolizumab Plus Bevacizumab Therapy in Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: A Multicenter Analysis
Oncology·2025· 2 cited
Neutrophil‐to‐lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis
Hepatology Research·2025· 4 citedOpen Access
The Effectiveness of Long-Term Continuation of Atezolizumab plus Bevacizumab in Patients Receiving Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: A Multicenter Study
Oncology·2025· 1 citedOpen Access
Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study
Oncology·2024· 1 cited
Multicenter epidemiological survey of pneumatosis intestinalis in Japan
BMC Gastroenterology·2022· 8 citedOpen Access
CCDC 835397: Experimental Crystal Structure Determination
The Cambridge Structural Database·2021Open Access
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial
˜The œLancet. Gastroenterology & hepatology·2021· 63 cited
Efficacies of first and second tumor necrosis factor inhibitors in refractory ulcerative colitis patients in real-world practice
Indian Journal of Gastroenterology·2020· 2 cited
CCDC 1454737: Experimental Crystal Structure Determination
The Cambridge Structural Database·2020Open Access
Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative Colitis
Journal of Clinical Medicine Research·2020· 10 citedOpen Access
Antitumor Effect of a Novel Photodynamic Therapy With Acetylated Glucose-conjugated Chlorin for Gastrointestinal Cancers
Anticancer Research·2019· 5 citedOpen Access
The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor‐α inhibitor
JGH Open·2019· 4 citedOpen Access
Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet’s disease
Digestive and Liver Disease·2019· 22 cited
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
Case Reports in Gastroenterology·2019· 9 citedOpen Access
Urinary Cysteine-Rich Protein 61 and Trefoil Factor 3 as Diagnostic Biomarkers for Colorectal Cancer
Translational Oncology·2019· 25 citedOpen Access
Trisomy 8-Associated Intestinal Behcet’s Disease That Achieved Complete Remission With Mesalazine
Journal of Medical Cases·2018Open Access
Su1721 THE ANALYSIS OF DETECTION TIME OF COLITIC CANCER AFTER DIAGNOSIS OF ULCERATIVE COLITIS: A SINGLE CENYER EXPERIENCE
Gastrointestinal Endoscopy·2018Open Access
Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn's Disease
Therapeutic Apheresis and Dialysis·2018· 14 cited
page 1 of 10Next →

Frequent Co-authors

Takashi Joh(28), Hiromi Kataoka(25), Tetsuya Tsukamoto(23), Satoshi Tanida(23), Masae Tatematsu(22), Takaya Shimura(15), Eiji Kubota(12), Toshio Kamiya(11), Yoshinori Mori(10), Naotaka Ogasawara(9), Makoto Sasaki(9), Mamoru Tanaka(8), Takashi Mizushima(8), Masahide Ebi(8), Ken‐ichi Inada(7), Harunari Tanaka(6), Keiji Ozeki(6), Hironobu Tsukamoto(6), Yoshitaka Yamamura(5), Toshiko Kumagai(5)